Hydroxyurea for the treatment of sickle cell disease
By: prepared by the Johns Hopkins University Evidence-based Practice Center ; investigators, Jodi B. Segal ... [et al.].
Contributors: Segal, Jodi B.; United States. Agency for Healthcare Research and Quality.; Johns Hopkins University. Evidence-based Practice Center.
Series: Evidence report/technology assessment -- no. 165; AHRQ publication -- no. 08-E 007
Publisher: Agency for Healthcare Research and Quality
Published: 2008
Place of publication: Rockville, MD
Language: eng
Number of pages: 95
ISBN-13: 9781587633430
Subjects: Sickle Cell Anemia -- Treatment; Antineoplastic agents -- Therapeutic use; Urea -- Derivatives -- Therapeutic use; Anemia, Sickle Cell -- drug therapy; Antineoplastic Agents -- therapeutic use; Hydroxyurea -- therapeutic use
Notes: "Contract no. 290-02-0018."

"February 2008."

Includes bibliographical references (p. 77-91).

Issued also online.